The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2022-08-15), Bristol-Myers Squibb Co's share price is $74.53. Bristol-Myers Squibb Co's Book Value per Share for the quarter that ended in Jun. 2022 was $15.27. Hence, Bristol-Myers Squibb Co's PB Ratio of today is 4.88.
The historical rank and industry rank for Bristol-Myers Squibb Co's PB Ratio or its related term are showing as below:
BMY'
s PB Ratio Range Over the Past 10 Years
Min: 2.19 Med: 5.24 Max: 9.54
Current: 4.87
During the past 13 years, Bristol-Myers Squibb Co's highest PB Ratio was 9.54. The lowest was 2.19. And the median was 5.24.
BMY's PB Ratio is ranked worse than 83.23% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs BMY: 4.87
During the past 12 months, Bristol-Myers Squibb Co's average Book Value Per Share Growth Rate was -7.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 24.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 19.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 7.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bristol-Myers Squibb Co was 33.60% per year. The lowest was -7.00% per year. And the median was 4.20% per year.
Back to Basics: PB Ratio
Bristol-Myers Squibb Co PB Ratio Historical Data
The historical data trend for Bristol-Myers Squibb Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bristol-Myers Squibb Co Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
PB Ratio
8.48
6.02
2.77
3.64
3.73
Bristol-Myers Squibb Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
PB Ratio
4.03
3.53
3.73
4.92
5.04
Competitive Comparison
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bristol-Myers Squibb Co PB Ratio Distribution
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's PB Ratio falls into.
Bristol-Myers Squibb Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Bristol-Myers Squibb Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bristol-Myers Squibb Co (NYSE:BMY) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bristol-Myers Squibb Co PB Ratio Related Terms
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.04(1.38%) Volume: 11,125,278 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BMY has been successfully added to your 
